| Date Filed | Type | Description |
| 07/31/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/27/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 5.5% stake in Honda Motor Co., Ltd |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 5.6% stake in Mitsubishi UFJ Financial Group, Inc. |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 6.3% stake in Mizuho Financial Group, Inc. |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 6.2% stake in Nomura Holdings, Inc. |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 6% stake in ORIX Corporation |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 6.7% stake in Sony Group Corporation |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 6.1% stake in Sumitomo Mitsui Financial Group, Inc. |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 5.9% stake in Takeda Pharmaceutical Company Limited |
| 02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 2.6% stake in Stratasys Ltd. |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 5% stake in Teladoc Health, Inc. |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 7% stake in 2U,Inc. |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 5.4% stake in Arcturus Therapeutics Holdings Inc. |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 6.8% stake in Blade Air Mobility, Inc. |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 4% stake in Cerus Corporation |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 0% stake in Compugen, Ltd. |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 5.1% stake in CRISPR Therapeutics AG |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 4.9% stake in Niu Technologies |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 5.2% stake in Organovo Holdings, Inc. |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 6.3% stake in Pacific Biosciences of California, Inc. |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 6% stake in PagerDuty, Inc. |
| 02/03/2023 |
SC 13G
| Sumitomo Mitsui Trust Holdings, Inc. reports a 6.4% stake in ROKU, INC. |
| 02/03/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/03/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/30/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/21/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/26/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/27/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/04/2022 |
SC 13G
| Sumitomo Mitsui Trust Holdings, Inc. reports a 5.7% stake in Teladoc Health, Inc. |
| 02/04/2022 |
SC 13G
| Sumitomo Mitsui Trust Holdings, Inc. reports a 5.4% stake in Pacific Biosciences of California, Inc. |
| 02/04/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2022 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 7.2% stake in PagerDuty, Inc. |
|